Normase Eps (Lactulose)

Lactulose, the active ingredient in Normase Eps, is an osmotic laxative presented as an oral formulation for oral use. It is employed to relieve constipation and to lower blood ammonia levels in patients with hepatic encephalopathy, thereby improving neurological function in individuals with liver disease. The drug works by drawing water into the colon, softening stools and facilitating the removal of nitrogenous waste.

GNH USA supplies Normase Eps as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Normase Eps (lactulose) acts as an osmotic laxative and ammonia‑lowering agent in the gastrointestinal tract.

- Constipation: softens stool and increases bowel frequency to relieve chronic constipation. - Hepatic encephalopathy: reduces intestinal ammonia absorption, helping prevent and treat episodes of hepatic encephalopathy. - Hyperammonemia in liver disease: lowers systemic ammonia levels, supporting neurological stability in patients with advanced liver dysfunction.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Flatulence: increased gas from bacterial fermentation. - Abdominal cramps: intermittent stomach discomfort. - Diarrhea: loose stools, especially at higher doses.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss that may need medical care. - Electrolyte imbalance: abnormal potassium or sodium levels. - Allergic reaction: rash, itching, or facial swelling.

When prescribing or dispensing lactulose, several safety considerations should be observed. - Assess renal function: adjust use in patients with impaired kidney clearance. - Monitor electrolytes: watch for potassium or sodium disturbances during prolonged therapy. - Use caution in diabetes: lactulose contains carbohydrate that may affect blood glucose. - Avoid abrupt discontinuation: taper dose to prevent rebound constipation. - Adjust dose in pediatric patients: follow pediatric dosing guidelines if applicable. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can influence the absorption or efficacy of certain medicines, requiring attention to possible drug interactions.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce lactulose’s osmotic effect. - Oral antibiotics with broad‑spectrum activity: can alter colonic flora and diminish lactulose conversion.

Moderate Interactions (Monitor Closely): - Digoxin: increased gastrointestinal transit may lower digoxin absorption. - Metformin: altered gut motility could affect metformin’s plasma levels. - Diuretics: combined risk of electrolyte imbalance, especially potassium loss.